Year None20202019201820172016 November 23, 2020 Medicenna to Participate in Upcoming December Investor Conferences Go to November 18, 2020 Medicenna Announces Upcoming Oral Presentations at the 2020 Society for Neuro-Oncology Annual Meeting Go to November 13, 2020 Medicenna Reports Second Quarter Fiscal 2021 Financial Results and Operational Highlights Go to November 2, 2020 Medicenna to Present at Upcoming Scientific and Investor Events in November Go to October 26, 2020 Medicenna Presents Promising Preclinical Data on IL-2 and IL-13 Superkines at the EORTC-NCI-AACR Annual Meeting Go to October 26, 2020 Medicenna Presents Late Breaking Abstract Updating Results from Phase 2b Recurrent GBM Trial at the 36th EORTC-NCI-AACR Meeting Go to Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page next › Last page last »
November 18, 2020 Medicenna Announces Upcoming Oral Presentations at the 2020 Society for Neuro-Oncology Annual Meeting Go to
November 13, 2020 Medicenna Reports Second Quarter Fiscal 2021 Financial Results and Operational Highlights Go to
October 26, 2020 Medicenna Presents Promising Preclinical Data on IL-2 and IL-13 Superkines at the EORTC-NCI-AACR Annual Meeting Go to
October 26, 2020 Medicenna Presents Late Breaking Abstract Updating Results from Phase 2b Recurrent GBM Trial at the 36th EORTC-NCI-AACR Meeting Go to
